creative ideation

Digital

Overview View our webinar which took place on Tuesday 23rd July at 16:00 BST / 11:00 EST / 08:00 PST.

News

Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.